Careers  |  Sign In  |  Register

Latest in Pharmacists

Reuters Health • The Doctor's Channel Daily Newscast

Trimethoprim-sulfamethoxazole questionable for pediatric soft-tissue infections

NEW YORK (Reuters Health) – Treatment of skin and soft-tissue infections (SSTIs) in children in regions where community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is prevalent is more likely to fail when trimethoprim-sulfamethoxazole or beta-lactams are used, rather than clindamycin, a...

Reuters Health • The Doctor's Channel Daily Newscast

Add-on dapagliflozin improves diabetes control without weight gain

NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss, according to the results of a trial reported in Diabetes Care online August 4. “Dapagliflozin is a...

Reuters Health • The Doctor's Channel Daily Newscast

Meta-analysis defines risk of congestive heart failure with sunitinib

NEW YORK (Reuters Health) - Pooled data suggest that cancer patients who are treated with sunitinib (Sutent; Pfizer) have about a 2-fold increased relative risk of developing high-grade congestive heart failure (CHF) and about a 3-fold increased risk of developing high-grade CHF. The absolute risks are...